The Effect of Ledipasvir/Sofosbuvir Treatment on Systolic and Diastolic Dysfunction in Patients with HCV-Related Decompensated Cirrhosis

dc.contributor.authorDemir, Mehmet
dc.contributor.authorDemir, Mehmet
dc.date.accessioned2024-09-18T21:01:48Z
dc.date.available2024-09-18T21:01:48Z
dc.date.issued2018
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.descriptionAnnual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting -- NOV 09-13, 2018 -- San Francisco, CAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.endpage1164Aen_US
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.startpage1164Aen_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/13015
dc.identifier.volume68en_US
dc.identifier.wosWOS:000446020503272en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofHepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe Effect of Ledipasvir/Sofosbuvir Treatment on Systolic and Diastolic Dysfunction in Patients with HCV-Related Decompensated Cirrhosisen_US
dc.typeConference Objecten_US

Dosyalar